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Background: Automated reporting of estimated glomerular filtration rate (eGFR) is a recent advance in laboratory
information technology (IT) that generates a measure of kidney function with chemistry laboratory results to aid
early detection of chronic kidney disease (CKD). Because accurate diagnosis of CKD is critical to optimal medical
decision-making, several clinical practice guidelines have recommended the use of automated eGFR reporting.
Since its introduction, automated eGFR reporting has not been uniformly implemented by U. S. laboratories despite
the growing prevalence of CKD. CKD is highly prevalent within the Veterans Health Administration (VHA), and
implementation of automated eGFR reporting within this integrated healthcare system has the potential to improve
care. In July 2004, the VHA adopted automated eGFR reporting through a system-wide mandate for software
implementation by individual VHA laboratories. This study examines the timing of software implementation by
individual VHA laboratories and factors associated with implementation.
Methods: We performed a retrospective observational study of laboratories in VHA facilities from July 2004 to
September 2009. Using laboratory data, we identified the status of implementation of automated eGFR reporting
for each facility and the time to actual implementation from the date the VHA adopted its policy for automated
eGFR reporting. Using survey and administrative data, we assessed facility organizational characteristics associated
with implementation of automated eGFR reporting via bivariate analyses.
Results: Of 104 VHA laboratories, 88% implemented automated eGFR reporting in existing laboratory IT systems by
the end of the study period. Time to initial implementation ranged from 0.2 to 4.0 years with a median of 1.8 years.
All VHA facilities with on-site dialysis units implemented the eGFR software (52%, p<0.001). Other organizational
characteristics were not statistically significant.
Conclusions: The VHA did not have uniform implementation of automated eGFR reporting across its facilities.
Facility-level organizational characteristics were not associated with implementation, and this suggests that
decisions for implementation of this software are not related to facility-level quality improvement measures.
Additional studies on implementation of laboratory IT, such as automated eGFR reporting, could identify factors
that are related to more timely implementation and lead to better healthcare delivery.Background
Since its development, automated laboratory reporting of
estimated glomerular filtration rate (eGFR) has facilitated
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reproduction in any medium, provided the or(CKD) [1]. To report eGFR, clinical laboratories imple-
ment software that calculates eGFR from equations
based on serum creatinine and demographic variables.
As a result, clinicians who receive laboratory reports of
eGFR in addition to serum creatinine may make more
informed clinical decisions. The importance of auto-
mated eGFR reporting was established by National Kid-
ney Foundation clinical guidelines in 2002, and, later,
endorsed by the National Kidney Disease Education. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sequent years [2-4]. Despite these endorsements, auto-
mated eGFR reporting uptake has been slow; only 40% of
U.S. clinical laboratories had eGFR reporting software by
2007 [5]. In other words, more than half of US laborator-
ies had not implemented eGFR reporting by 2007, and
physicians served by those laboratories may have missed
opportunities for early detection of CKD. Because of the
complications associated with late detection of CKD and
increasing prevalence of CKD [6,7], it is important to
understand the mechanisms associated with implementa-
tion of automated eGFR reporting. Implementation of
automated eGFR reporting could be explained by
organizational characteristics [8], but that relationship has
not been studied to date.
For clinicians within the Veterans Health Administra-
tion (VHA), detection of CKD is important because the
prevalence of CKD among veterans is expected to grow
due to aging and increasing prevalence of diabetes and
hypertension [6]. To enhance detection and manage-
ment of CKD, the VHA adopted system-wide automated
eGFR reporting by providing a software patch for exist-
ing laboratory information technology (IT) systems in
2004. The software patch was programming code that
enabled each laboratory’s IT system to calculate eGFR
with the Modification of Diet in Renal Disease (MDRD)
equation and report eGFR values with every serum cre-
atinine. To implement automated eGFR reporting, each
laboratory had to install and activate the software patch.
Although software patch implementation is typically
issued as a mandate, for unclear reasons, implementa-
tion of this patch was left to the discretion of individual
laboratories. Without a mandate or a central mechanism
for simultaneous implementation in all laboratories, the
VHA laboratories provide a natural experiment for ob-
serving implementation of automated eGFR reporting in
a large, national, vertically-integrated healthcare system.
Individual VHA laboratories may have rates of imple-
mentation of automated eGFR reporting that differ from
non-VHA laboratories because the VHA is a highly inte-
grated health system with a system-wide electronic
health record and a strong reputation in quality per-
formance [9]. This study examines the timing of imple-
mentation of automated eGFR reporting across the
VHA. In addition, we sought to identify organizational
characteristics that could explain the rate of implemen-
tation observed not only in the VHA, but also within la-
boratories in other healthcare systems.
Methods
Study Design and Population
We performed a retrospective observational study of
VHA laboratories and their affiliated clinical facilities. The
study population was derived from VHA community-based outpatient clinics (CBOCs) or Veteran Affairs
medical centers (VAMCs) with available laboratory data
between July 2004 and September 2009. VHA facilities
that did not have complete laboratory and organizational
data, or were not independent VHA facilities (e.g., skilled
nursing facilities, rehabilitation centers, and domiciliaries)
were excluded. This study was approved by the Institu-
tional Review Board of the Durham Veterans Affairs Med-
ical Center.
Data Sources
Time to eGFR software implementation at each VHA la-
boratory was derived from administrative data in the
VHA Decision Support System’s Laboratory Results Na-
tional Data Extract (DSS-NDE) between July 2004 and
September 2009. Each of the creatinine and eGFR la-
boratory results had an associated date on which the la-
boratory tests were measured. These dates were used to
identify the presence and timing of eGFR implementa-
tion by VHA facility.
Organizational data come from several sources. The pri-
mary source of organizational data was the 2006 VHA
Clinical Practice Organizational Survey-Chief of Staff
Module (CPOS-COS survey), a survey of facility quality
improvement (QI) characteristics and activities. Survey
items were carefully selected to match organizational
domains of our conceptual model (Table 1). Additional
organizational characteristics were obtained from VHA
administrative data. Facility complexity was captured
through the 2005 VHA Facility Complexity Score Model,
maintained by the VHA National Leadership Board. VHA
facilities with dialysis services were identified through
clinic-specific utilization codes in the DSS-NDE.
Measurement
We developed three eGFR implementation outcomes for
each facility: 1) a dichotomous indicator of implementa-
tion status by September 2009; 2) time to initial imple-
mentation of automated eGFR reporting (between July
2004 and September 2009); and 3) time to full implemen-
tation of automated eGFR reporting (between July 2004
and September 2009). For time to initial implementation,
time zero was defined as the date of VHA’s issued
mandate for eGFR reporting to laboratory information
managers (July 14, 2004). Based on administrative data,
some facilities appeared to intermittently report eGFR
values after time zero before consistently reporting eGFR
per the mandate. Thus, initial implementation date was
based on consistent eGFR reporting, with consistency
attained when at least 1% of the median creatinine tests
per month were accompanied by a reported eGFR. Time
to full implementation was defined as the time between
initial implementation and the day when at least 90% of
median creatinine tests per month were accompanied by a
Table 1 Domains, Definitions, and Variables of the Conceptual Model of Implementation of eGFR reporting
Domain Definition1 Variable
Facility context Characteristics of the medical
centers that may affect implementation
Number of acute care beds; Facility complexity score2; Affiliation with
an academic medical center; Presence of nephrologists; Presence
of a dialysis unit
Implementation
activities and Structures
Approaches used to directly
introduce, spread, and
support the implementation
Use of clinical champions; Monitoring of guideline implementation;
Fostering of collaboration among facilities; Presence of plan for
implementation; Presence of teamwork for implementation; Available
financial resources for implementation
Staff awareness
and capabilities
Characteristics of staff responsible
for implementing the innovation
Resistance from Primary Care Providers; Subspecialists; Local Support
staff to QI
1 Definitions derived from Van Deusen Lukas’ conceptual model. Adapted from Table 2 of Reference [10]. 2 Facility complexity is a composite measure describing
patient volume, level of intensive care services, patient risk, residency slots, research funds, and specialty physicians at VHA facilities.
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plementation stages (early, mid, and late-stage) based on
tertile distributions of time to initial implementation.
Facilities that did not implement eGFR reporting by the
end of our observation period were grouped separately.
To identify organizational characteristics associated with
implementation of automated eGFR reporting, we selected
a conceptual model that has been used in prior studies to
evaluate organizational characteristics associated with
implementing new clinical innovations within the VHA.
We applied Van Deusen Lukas and colleagues’ conceptual
model of implementation, which posits that implementa-
tion of a clinical innovation is influenced by 1) facility
context, 2) implementation activities and structures, and 3)
staff awareness and capabilities [10]. Then, we identified
variables to match this conceptual model to test forTable 2 Survey items extracted from the VHA clinical practice
Survey Item
How many active acute care beds are in each major
bedsection of your hospital?
Does your VA have an academic medical school training
program for residents?
Which of the following types of specialty-trained physicians
(Nephrologists) do you have onsite at your VA?
To what extent do you think each of the following serves as a
barrier to improving performance at your facility?
Resistance from Primary Care providers
- Resistance from Subspeciality providers
- Resistance from Local Support staff
- Limited financial resources to support needed changes
To what extent has your facility implemented the following actions
to improve your VA’s clinical performance?
Designated a site champion for specific clinical guidelines or performance
- Monitored the pace at which guidelines were implemented across the fa
Fostered collaboration among facilities in guideline implementation withi
In the past year, when clinical practice guidelines were implemented
in your facility, to what extent:
Did teamwork exist at your facility in implemented the guidelines?
Were key implementation steps planned?association with implementation of automated eGFR
reporting (Table 1). The facility context domain includes
characteristics of each VHA facility, such as availability
and demand for specific clinical services, which may
affect implementation. The next domain, implementation
activities and structures, assesses the use of methods that
facilitate spread of implementation. Variables for this do-
main were CPOS-COS survey questions that measured
methods for QI and clinical practice guideline implemen-
tation (Table 2). Each of the methods selected have been
considered important facilitators of QI activities [11].
Other CPOS-COS survey QI activities were not included
in our primary analysis because they did not seem relevant
to implementation of automated eGFR reporting. Instead,
these QI activities were included in a sum to assess for an





Not a barrier; Small barrier; Moderate
barrier; Large Barrier




Not at all; Very little; Some; Great; Very great
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conceptual model, staff awareness and capabilities,
acknowledges that staff opinions on the implementation of
automated eGFR reporting are important. Variables for this
domain are derived from CPOS-COS survey questions
(Table 2).
CPOS-COS survey questions were deliberately selected to
match the domain definitions of the conceptual model. Al-
though these questions are not specific to automated eGFR
reporting, they have been validated for general QI innova-
tions (unpublished data from co-author Elizabeth M. Yano).
Data for each variable was obtained from Likert scale ques-
tions by collapsing four-level or five-level survey responses
into dichotomous variables. The distribution of responses to
the five-level survey questions was examined to classify the
middle level responses into either dichotomous variable. As
dichotomous variables, the survey responses were inter-
preted as the presence or absence of the organizational
characteristics of interest.
Analysis
To detect variation in time to initial implementation and
time to full implementation of eGFR reporting, we exam-
ined univariate distributions. To identify differences by
implementation status and between implementationFigure 1 Proportion of Facilities that Implemented Automated eGFR
eGFR reporting during the study period (n=92), this line plot depicts time to inistages, we conducted ANOVA and t-tests for continuous
variables and Chi-square or Fisher’s exact tests for cat-
egorical variables. We performed simple logistic regres-
sions to determine the strength of association between
each organizational characteristic and implementation of
eGFR reporting. To test for association with time to im-
plementation, survival analysis was performed using pro-
portional hazards models. Variables forced into the
multivariable regression model included presence of a dia-
lysis unit, presence of nephrologists, and affiliation with an
academic medical center. A backwards elimination proced-
ure was performed to fit additional variables into the model
if the significance level was less than 0.2. Nonparametric
tests were applied when data were not normally distributed.
Alpha levels for statistical significance were set at 0.05.
Results
Implementation Rates
Although we identified 135 eligible facilities, only 104 fa-
cilities had complete organizational data, so 31 facilities
were excluded from the analyses. Of the 104 facilities
included, 92 (88%) facilities implemented eGFR reporting
by the end of the study period. Time to initial implementa-
tion varied widely, from 0.2 to 4.0 years (median=1.8 years)
from the VHA’s initial mandate for adoption (Figure 1).Reporting over time. For the facilities that implemented automated
tial implementation measured in years from the date of software availability.
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automated eGFR reporting with a similar median time to
initial implementation (1.6 years), while the remaining
facilities did not implement.
After the initial implementation of eGFR reporting soft-
ware, several months passed before eGFR values were
automatically reported consistently with all creatinine
results at many facilities. The median time between initial
implementation and full implementation (defined as the
time between initial implementation and the date when
≥90% of median creatinine tests were accompanied by a
reported eGFR) was 0.8 years (IQR=0.42). By the end of
the study period, 5 of the 92 facilities that initiated the
software did not attain full implementation.
Organizational characteristics associated with
implementation
Facility context was associated with implementation of
automated eGFR reporting to some extent. Facilities oper-
ating a dialysis unit were more likely to implement auto-
mated eGFR reporting (52%, p<.001) (Table 3). However,
implementation status was not associated with facility size
(e.g., number of beds), facility complexity, presence of
practicing nephrologists, or academic affiliation.Table 3 Organizational characteristics by implementation sta
Characteristic Overall N=104 Implement
Facility context
Number of Acute Care Beds (mean±SD) 115.9±87.4 118.5±89.4
Facility Complexity Score2
Level 1 56 (54) 50 (89)
Level 2 20 (19) 17 (85)
Level 3 28 (27) 25 (89)
Presence of Nephrologist 72 (69) 64 (89)
Presence of Dialysis Unit 54 (52) 54 (100)
Affiliation with Academic Medical Center 84 (81) 72 (86)
Implementation activities and structures
Use of Clinical Champions3 93 (90) 81 (87)
Monitoring of Guideline Implementation 89 (86) 78 (89)
Presence of Plan for Implementation 98 (94) 86 (88)
Fostering of Collaboration among facilities3 91 (88) 80 (88)
Presence of Teamwork for Implementation 100 (96) 88 (88)
Adequate Financial Resources 30 (29) 25 (83)
Staff awareness and capabilities
Resistance from Primary Care Providers 17 (16) 17 (100)
Resistance from Subspecialists 20 (19) 20 (100)
Resistance from Local Support Staff 8 (8) 8 (100)
Values represented are frequency (percentage). 1Odds ratio (95% confidence interv
2 Complexity level 1 facilities had highest complexity and level 3 the lowest.3 N=103Measures of implementation activities and structures
were favorable for most VHA facilities. A majority of fa-
cilities (>85%) utilized clinical champions and monitor-
ing of guideline implementation (general measure across
conditions, not specific to CKD treatment), and there
were no statistically significant differences by implemen-
tation status (p=0.60 and p=0.52, respectively) (Table 3).
Similarly, the use of key implementation steps and col-
laboration between facilities were common for both fa-
cilities that implemented the software and facilities that
did not implement (p=1.00 and p=0.70, respectively).
Only a minority of facility chiefs of staff (29%) perceived
adequacy of financial resources to support innovations,
and this perception was similar in both groups (p=0.30).
Regardless of implementation status, there was high use
of QI activities, median=10 (maximum=11, IQR=3 for
facilities that did implement, IQR=1.5 for facilities that
did not implement, p=0.27). For measures of staff
awareness and capabilities, resistance from primary
care, subspecialists, and support staff as a barrier to QI
was uncommon, and these measures also did not differ
by implementation status (p=0.20, p=0.12, and p=0.59,
respectively). Odds ratios (shown in Table 3) revealed no
significant associations between the variables derivedtus





6 (11) 0.86 1.19 (0.36-3.97)
3 (15) 0.68 (0.16-2.78)
3 (11) 1.12 (0.28-4.47)
8 (11) 1.00 1.14 (0.32-4.11)
0 (0) <0.001 35.39 (2.03-615.93)
8 (14) 0.12 0.14 (0.01-2.49)
12 (13) 0.60 0.31 (0.02-5.64)
11 (12) 0.52 0.51 (0.06-4.24)
12 (12) 1.00 0.53 (0.03-10.04)
11 (12) 0.70 0.66 (0.08-5.63)
12 (12) 1.00 0.79 (0.04-15.51)
5 (17) 0.30 0.52 (0.15-1.80)
0 (0) 0.20 5.79 (0.33-102.62)
0 (0) 0.11 7.07 (0.40-124.54)
0 (0) 0.59 2.51 (0.14-46.32)
al).
for this survey question.
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mated eGFR reporting.
To relate timing of implementation to organizational
characteristics, facilities were categorized into stages of
implementation, early, mid, or late stage with median
time to implementation of 0.6, 1.8, and 3.2 years, re-
spectively. In our examination of these stages, early stage
facilities tended to be associated with more acute care
beds, higher facility complexity scores, and more neph-
rology services compared to mid stage and late stage fa-
cilities (Table 4). However, none of these measures of
facility context were significantly different between these
groups or in a comparison of early and late stage facil-
ities. In addition, there were no significant differences
between facility stages for measures of implementation
activities and structures (including total QI activities)
and staff awareness and capabilities.
Unadjusted hazard ratios of the organizational charac-
teristics revealed no associations with time to implemen-
tation of automated eGFR reporting. In a multivariable
model for time to implementation, “presence of team-
work for implementation” was retained in a model with
three other variables (presence of dialysis unit, presence
of nephrologist, and affiliation with academic medical
center), although this organizational characteristic was
not statistically significant in the full model.Table 4 Organizational characteristics by stage of initial impl
Characteristics Stage N=31
Facility Context
Number of Acute Care Beds1 123.6±91.2
Facility Complexity Score2
Level 1 19 (61)
Level 2 5 (16)
Level 3 7 (23)
Presence of Nephrologists 23 (74)
Presence of Dialysis Unit 21 (68)
Affiliation with Academic Medical Center 25 (81)
Implementation activities and structures
Use of Clinical Champions3 27 (90)
Monitoring of Guideline Implementation 27 (87)
Presence of Plan for Implementation 29 (94)
Fostering of Collaboration among facilities3 27 (87)
Presence of Teamwork for Implementation 29 (94)
Adequate Financial Resources 6 (19)
Staff awareness and capabilities
Resistance from Primary Care Providers 7 (23)
Resistance from Subspecialists 7 (23)
Resistance from Local Support Staff 4 (13)
1 Mean (Standard deviation); all other values represented are frequency (percentage
lowest.3 N=103 for this survey question.Discussion
Despite an emphasis on quality performance and a
system-wide electronic health record, implementation of
automated eGFR reporting among VHA laboratories
was incomplete and varied over many years following its
adoption mandate. This wide variation could not be
explained by facility-level organizational characteristics
as there were no significant differences in these charac-
teristics between the stages of implementation. There
was only one significant difference by implementation
status: presence of dialysis services was associated with
implementation. Importantly, delayed or absent imple-
mentation of automated eGFR reporting could have
translated into missed opportunities for earlier diagnoses
of CKD among US veterans. Also, these findings illus-
trate that implementation of laboratory IT is not asso-
ciated with level of healthcare system integration or
presence of facility-level QI characteristics.
Rates of implementation of automated eGFR reporting
have been evaluated in other studies. A survey from non-
VHA settings in 2007 revealed that 40% of U.S. clinical la-
boratories reported eGFR with creatinine values in 2007
[5].That same year, the College of American Pathologists’
Annual Survey revealed eGFR reporting was used in ap-
proximately 50% of laboratories [12]. In the current study,
we found that approximately 68% of VHA laboratoriesementation
Mid Stage N=30 Late Stage N=31 P Value
117.1±93.0 114.9±86.9 0.93
18 (60) 13 (42) 0.51
4 (13) 8 (26)
8 (27) 10 (32)
22 (73) 19 (61) 0.47
18 (60) 15 (48) 0.30
25 (83) 22 (71) 0.46
27 (90) 27 (87) 0.92
26 (87) 25 (81) 0.73
29 (97) 28 (90) 0.87
28 (93) 25 (83) 0.49
29 (97) 30 (97) 1.00
11 (37) 8 (26) 0.31
3 (10) 7 (23) 0.35
4 (13) 9 (29) 0.33
1 (3) 2 (7) 0.40
). 2 Complexity level 1 facilities had highest complexity and level 3 the
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tions of automated eGFR reporting usage were obtained
by different methods, they all show a similar trend of in-
complete implementation many years from initial software
availability and consensus recommendations. This data
suggests VHA laboratories had higher prevalence of auto-
mated eGFR reporting than non-VHA laboratories in
2007, and this may be explained by the VHA’s highly inte-
grated healthcare system and electronic health record. Al-
though when compared to another large integrated
healthcare system, Alberta Health Services in Alberta,
Canada, VHA laboratories had gradual implementation. In
2004, both healthcare systems adopted eGFR reporting
software, but only Alberta Health Services had complete
implementation of automated eGFR reporting software in
its laboratories within that year [13]. Given that imple-
mentation of this innovation can vary regardless of system
integration, more specific organizational characteristics
likely explain this variation.
We sought to identify specific organizational charac-
teristics that describe the variation in implementation of
automated eGFR reporting within the VHA. Our ana-
lyses revealed that facilities that implemented the soft-
ware were more likely to provide dialysis services than
facilities that did not implement. In the VHA, facilities
with dialysis units typically offer tertiary care services,
and the demands of a more complex patient population
and the better availability of financial resources in these
facilities differs from facilities that provide only primary
care services. As a result, the association of dialysis ser-
vices to implementation of automated eGFR reporting
suggests that presence of dialysis services may be highly
correlated with one or all of the following: 1) presence
of other resources in a facility, such as experienced la-
boratory information technology staff; 2) high demand
to provide complex medical services (so facility is more
apt to incorporate new innovations); or 3) efficient chain
of command (facilities with dialysis units are larger and
may incorporate more organizational hierarchy that pro-
motes better accountability to tasks). Overall, the associ-
ation of implementation of automated eGFR reporting
and presence of dialysis services is consistent with previ-
ous research that indicates environmental barriers, such
as lack of resources, may reduce provider adherence to
clinical practice guidelines [14].
Aside from this finding, none of the other organizational
characteristics were associated with implementation of
automated eGFR reporting. These null results may have
occurred because the variables used to describe the
organizational domains of the conceptual model were only
surrogate measures of implementation of automated eGFR
reporting (Table 1). For example, the use of clinical cham-
pions is an important tool for implementation of health-
care innovations [15], and the CPOS-COS survey item forthis variable was examined as a surrogate measure to de-
termine whether use of clinical champions is important
for implementation of automated eGFR reporting. All of
the facilities reported similar frequencies in use of clinical
champions for general QI initiatives. Although these simi-
larities exist for general QI initiatives, the survey didn’t so-
licit the opinions of laboratory personnel to directly assess
the use of clinical champions in implementation of auto-
mated eGFR reporting. As a result, the importance of clin-
ical champions cannot be ruled out because our methods
don’t include direct measurement of this variable. Simi-
larly, all other organizational variables and domains from
the conceptual model should be measured more directly
before one concludes that there is no association with im-
plementation of automated eGFR reporting. A similar
survey distributed to laboratory personnel could provide
more direct and specific assessment of these organizational
variables. Not only that, direct query of laboratory decision-
making processes or laboratory and IT leadership opinions,
could provide more insight beyond the domains of this
conceptual model.
We did not expect to find that none of the facility level
characteristics from the CPOS-COS survey were associated
with time to implementation of automated eGFR report-
ing. Intrinsic to our study design, we used the CPOS-COS
survey for facility-level organizational variables because
other similar studies demonstrated variable performance
and practice patterns among VHA facilities that are related
to facility- and clinic-level organizational characteristics
[10,16-21]. We further justified use of the CPOS-COS sur-
vey because general QI characteristics can affect imple-
mentation of new innovations in individual facilities [22].
Conversely, our results show that general QI characteristics
were not predictive of implementation of automated eGFR
reporting. Automated eGFR reporting and other laboratory
IT innovations are implemented differently from clinical
innovations and are less affected by the extent of clinical
QI infrastructure. This is an important lesson for future
studies that attempt to assess the role facility-level
organizational characteristics have in implementation of
laboratory IT innovations.
This study has limitations that should be acknowledged.
First, we did not assess laboratory-specific organizational
characteristics for association with implementation of
automated eGFR reporting. Without laboratory-specific
variables, an explanation for the delayed implementation
of automated eGFR reporting remains unclear. Second,
we could not use verified start dates (of implementation)
for each facility because of data transmission errors within
the administrative data. As a result, we derived a definition
for initiation of automated eGFR reporting that provided
approximate dates of implementation. Last, the retro-
spective study design limited the data available for analysis
of the process of software implementation. To counter
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responses to obtain organizational characteristics that
were measured within two years of the VHA’s initial adop-
tion of automated eGFR reporting in 2004.
The wide variation in implementation of automated
eGFR reporting in the VHA and other laboratories draws
attention to the ongoing need for quality improvement in
CKD management. Over the past decade, there has been
interest in improving CKD identification, and automated
eGFR reporting has been endorsed as a tool to enhance
detection of CKD [2-4]. In fact, many studies, as described
in a systematic review, have shown that automated eGFR
reporting is associated with earlier detection of CKD [1].
Consequently, CKD detection may have been delayed in
some VHA facilities as a result of the wide variation in im-
plementation of automated eGFR reporting. This potential
delay in diagnoses could be associated with disparate
health outcomes between veterans who receive care at
eGFR reporting facilities and those who do not. Specific-
ally, late diagnosis of CKD leads to late nephrology referral
which has been associated with increased mortality among
those who progress to kidney failure [23]. Because of in-
consistent implementation of automated eGFR reporting
in other U.S. laboratories, disparate health outcomes may
also exist outside the VHA. Given the growing prevalence
of CKD, a concerted effort to enhance early detection and
management of CKD remains important to prevent ad-
verse outcomes and slow disease progression [6,24].
This study also has implications for future laboratory
reporting innovations in nephrology. Although labora-
tories currently report eGFR from the MDRD equation,
the MDRD equation may eventually be replaced by newer
estimating equations, such as the Chronic Kidney Disease
Epidemiology Collaboration (CKD-EPI) equation or esti-
mates based on alternative biomarkers (e.g., cystatin-C)
[25,26]. Alternative equations for estimation of GFR will
necessitate the development and activation of additional
software patches in clinical laboratories in the VHA and
worldwide. Without a clear perspective on predictors of
implementation, widespread implementation of additional
eGFR reporting equations may be delayed.
Although we did not identify organizational character-
istics clearly associated with rate of implementation of
automated eGFR reporting, further investigation is war-
ranted to inform implementation of future laboratory IT
innovations which may lead to timely implementation
and improved disease management. Future studies could
include a qualitative analysis of facilities that did not im-
plement automated eGFR reporting to reveal barriers to
implementation. These barriers could be further evaluated
prospectively with the implementation of similar labora-
tory IT. Additionally, an effort to develop a conceptual
model specific for laboratory IT could enhance further
implementation research.Conclusions
There is evidence that VHA laboratories, in addition to
non-VHA laboratories, demonstrated a variable rate of
software implementation for automated eGFR reporting.
The rationale for this remains unclear, and it may be
explained by future studies that evaluate laboratory-
specific organizational characteristics. Without better
awareness of barriers to implementation of automated
eGFR reporting, a similar pattern of implementation
may occur with future laboratory IT innovations which
may limit their effectiveness in medical decision-making.
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